Granutec Completes Loperamide Recall Involving High Impurity Levels
This article was originally published in The Tan Sheet
Over 400 lots of OTC loperamide 2 mg tablets have been voluntarily recalled by Granutec as a result of impurities detected in product batches. The recall was completed at the beginning of February, according to the Novopharm subsidiary.
You may also be interested in...ï»¿
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC